vTv Therapeutics Inc. (VTVT)
USD 14.92
(-3.56%)
USD 14.92
(-3.56%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | -18.51 Million | -16.02 Million | -19.3 Million | -18 Million | -23.01 Million | -26.85 Million |
| Net Income | -20.25 Million | -25.07 Million | -17.73 Million | -12.8 Million | -21.93 Million | -23.84 Million |
| Depreciation & Amortization | 90 Thousand | 92 Thousand | 89 Thousand | 94 Thousand | 39 Thousand | 218 Thousand |
| Deferred income taxes | -3 Million | - | - | -3.97 Million | -1.11 Million | 626 Thousand |
| Stock-based compensation | 1.57 Million | 1.27 Million | 2.35 Million | 1 Million | 1.51 Million | 2.67 Million |
| Change in working capital | 4.39 Million | 5.38 Million | 35 Thousand | -2.7 Million | -2.05 Million | -7.54 Million |
| Other non-cash items | -1.32 Million | 2.3 Million | -4.05 Million | 380 Thousand | 532 Thousand | 1.01 Million |
| Investing Cash Flow | 4.4 Million | -21 Thousand | - | - | 242 Thousand | 7000.00 |
| Investments in PPE | - | -21 Thousand | - | - | -70 Thousand | -5000.00 |
| Acquisitions | 4.4 Million | - | - | - | 312 Thousand | 12 Thousand |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | 4.4 Million | - | - | - | - | - |
| Other Investing Activities | -4.4 Million | - | - | - | 312 Thousand | 12 Thousand |
| Financing Cash Flow | 11.99 Million | 14.75 Million | 26.97 Million | 19.47 Million | 22.87 Million | 16.61 Million |
| Debt repayment | -33 Thousand | -808 Thousand | -715 Thousand | -5.45 Million | -10.57 Million | -5.38 Million |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | 992 Thousand | - |
| Common Stock Issuance | 12.03 Million | 5.04 Million | 26.75 Million | 24.42 Million | 32.94 Million | 21.5 Million |
| Other Financing Activities | 12.03 Million | 10.52 Million | 934 Thousand | 500 Thousand | 500 Thousand | 500 Thousand |
| Accounts receivables | 71 Thousand | -116 Thousand | 101 Thousand | -153 Thousand | -5000.00 | 8 Million |
| Accounts payables | 2.92 Million | -856 Thousand | 1.82 Million | -997 Thousand | -618 Thousand | -6.19 Million |
| Inventory | - | - | -889 Thousand | -1.97 Million | 618 Thousand | - |
| Other working capital | 1.39 Million | 6.35 Million | -1 Million | 420 Thousand | -2.04 Million | -15.54 Million |
| Cash at beginning of period | 12.12 Million | 13.41 Million | 5.74 Million | 4.27 Million | 4.18 Million | 14.42 Million |
| Cash at end of period | 9.44 Million | 12.12 Million | 13.41 Million | 5.74 Million | 4.27 Million | 4.18 Million |
| Capital Expenditure | - | -21 Thousand | - | - | -70 Thousand | -5000.00 |
| Effect of forex changes on cash | - | - | - | - | - | - |
| Net cash flow / Change in cash | -2.68 Million | -1.28 Million | 7.66 Million | 1.47 Million | 94 Thousand | -10.23 Million |
| Free Cash Flow | -18.51 Million | -16.04 Million | -19.3 Million | -18 Million | -23.08 Million | -26.86 Million |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -5.18 Million | -4.86 Million | -20.25 Million | -3.47 Million | -8.54 Million | -7.21 Million |
| Depreciation & Amortization | 23 Thousand | 22 Thousand | 90 Thousand | 23 Thousand | 22 Thousand | 23 Thousand |
| Deferred income taxes | - | - | -3 Million | 108 Thousand | - | -3.78 Million |
| Stock-based compensation | 859 Thousand | 220 Thousand | 1.57 Million | 403 Thousand | 433 Thousand | 399 Thousand |
| Change in working capital | -1 Million | -1.92 Million | 4.39 Million | 1.28 Million | -48 Thousand | 1.26 Million |
| Other non-cash items | 748 Thousand | 1.87 Million | -1.32 Million | -1.25 Million | 3.29 Million | 3.15 Million |
| Investing Cash Flow | - | - | 4.4 Million | 4.4 Million | - | - |
| Investments in PPE | - | - | - | - | - | - |
| Acquisitions | - | - | 4.4 Million | - | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | 4.4 Million | 4.4 Million | - | - |
| Other Investing Activities | - | - | -4.4 Million | 4.4 Million | - | - |
| Financing Cash Flow | - | 50.14 Million | 11.99 Million | -282 Thousand | 473 Thousand | - |
| Debt repayment | - | -191 Thousand | -33 Thousand | -282 Thousand | -473 Thousand | -12.03 Million |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | -1.27 Million | - | - |
| Common Stock Issuance | - | 50.33 Million | 12.03 Million | 12.03 Million | 12.03 Million | 12.03 Million |
| Other Financing Activities | - | 50.33 Million | 12.03 Million | 12.06 Million | 566 Thousand | - |
| Accounts receivables | 675 Thousand | -879 Thousand | 71 Thousand | -102 Thousand | - | - |
| Accounts payables | -1.94 Million | -1.51 Million | 2.92 Million | 659 Thousand | 500 Thousand | 738 Thousand |
| Inventory | - | - | - | - | - | - |
| Other working capital | 256 Thousand | 461 Thousand | 1.39 Million | 729 Thousand | -548 Thousand | 522 Thousand |
| Cash at beginning of period | 52.25 Million | 9.44 Million | 12.12 Million | 8.23 Million | 12.59 Million | 18.76 Million |
| Cash at end of period | 45.52 Million | 52.25 Million | 9.44 Million | 9.44 Million | 8.23 Million | 12.59 Million |
| Capital Expenditure | - | - | - | - | - | - |
| Effect of forex changes on cash | - | - | - | - | - | - |
| Net cash flow / Change in cash | -6.72 Million | 42.8 Million | -2.68 Million | 1.2 Million | -4.36 Million | -6.16 Million |
| Free Cash Flow | -6.72 Million | -7.33 Million | -18.51 Million | -2.91 Million | -4.83 Million | -6.16 Million |
SUS
MRMD
MTO
1798
4731
ROSB